Topic: Achillion Pharmaceuticals Inc
A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:. Datawatch Corp. rose 36.7 percent to $8.60.. Cepheid rose 25.6 ...
Amgen and Celgene , looking to boost oncology offerings, announced separate deals for small biotech companies Thursday, the latest in what analysts...
0 create a portfolio now:. XAddBristol-Myers Squibb Co. (BMY) XAddInhibitex Inc. (INHX) XAddIdenix Pharmaceuticals Inc. (IDIX) Add . Create ...
A tiny Israeli drug maker that few investors have ever heard of announces a licensing deal Tuesday with a French company similarly unknown, but the...
Equities research analysts at Brean Murray raised their price target on shares of Achillion Pharmaceuticals Inc (NASDAQ: ACHN) from $9.00 to $20.00...
Equities research analysts at ThinkEquity raised their price target on shares of Achillion Pharmaceuticals Inc (NASDAQ: ACHN) from $10.00 to $20.00...
Achillion Pharmaceuticals Inc (NASDAQ: ACHN)'s stock had its "buy" rating reaffirmed by equities research analysts at ThinkEquity in a research...
4,333,232 shares of Achillion Pharmaceuticals Inc (ACHN) traded hands on Monday, a 450.87% increase in volume compared to its 20-day average. The...
Even if you're late to the break-out party, Idenix Pharmaceuticals (IDIX) is still an intriguing market mover worth watching. . . On Thursday, we...
The conventional wisdom after Gilead Sciences' (GILD) recently announced $11 billion takeover of hepatitis drug developer Pharmasset (VRUS) is that...